Doctoral researcher - Restoring aberrant cell differentiation with peptidic β-catenin ligandsContract Type:Fixed Term ContractDuration:36 MonthAbout usThe University of Luxembourg is an international research university with a distinctly multilingual and interdisciplinary character. The Faculty of Science, Technology and Medicine (FSTM) at the University of Luxembourg contributes multidisciplinary expertise in the fields of Mathematics, Physics, Engineering, Computer Science, Life Sciences and Medicine. Your role
The research project within a MSCA-Doctoral Network will be carried out in the research group of Prof. Dr. Daniel Abankwa. β-catenin is a central regulator of cell differentiation and stemness. Aberrant Wnt/β-catenin activity can drive developmental defects and cancer. This project tests whether context-specific peptidic ligands targeting β-catenin can restore aberrant differentiation. Using C2C12 myoblasts, you will combine cellular differentiation assays, signalling and confocal localisation studies with dedicated BRET biosensors to measure intracellular protein–protein interactions and target engagement. The resulting mechanistic read-outs will feed back into iterative β-catenin ligand optimisation within FlexCAT. Your profile
Academic Eligibility (Thesis): Applicants must demonstrate at least B2-level proficiency in the language of their thesis. For details and accepted certificates, please visit the Application for admission – Doctoral Candidates. We offer
How to applyImportant Application Instructions Please note that applications must be submitted exclusively through the FlexCAT Recruitment Portal: https://phd-recruiting.medunigraz.at/. When accessing this website, please follow the steps below to complete your application:
Please note that applications submitted through any other channel, including by email, cannot be considered.
|














